logo
Select company
Select metric
$ 3.95MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
28
Sector
51
Industry
63
History
69
$ 9.03Close
$ 1.1 - $ 9.52 52-Week Range
Ticker Information

Ticker

TNGX

Company Name

TANGO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TANGO THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNGX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 3.95M
3/31/2025$ 4.68M
12/31/2024$ 47.66M
9/30/2024$ 47.54M
6/30/2024$ 125.59M
3/31/2024$ 124.87M
12/31/2023$ 81.96M
9/30/2023$ 81.64M
6/30/2023$ 1.3M
3/31/2023$ 1.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TANGO THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 172.11M.
  • Over the past 5 years, TANGO THERAPEUTICS INC's average CF - Equity has been $ 98.72M.
  • The median CF - Equity for TANGO THERAPEUTICS INC during this period was $ 47.66M
  • TANGO THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 328.63M.
  • The lowest CF - Equity recorded by TANGO THERAPEUTICS INC in the same timeframe $ -310K

TANGO THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
VIR : VIR BIOTECHNOLOGY INC $ 4.33MQURE : UNIQURE NV $ 82.79MNUVB : NUVATION BIO INC $ 5.21MAUTL : AUTOLUS THERAPEUTICS PLC $ 192KABUS : ARBUTUS BIOPHARMA CORP $ 6.43MZBIO : ZENAS BIOPHARMA INC $ 237.65MBCYC : BICYCLE THERAPEUTICS PLC $ 181KALMS : ALUMIS INC $ 234.12MFHTX : FOGHORN THERAPEUTICS INC $ 1.45MIMNM : IMMUNOME INC $ 193.92M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

TNGX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -310K

Minimum

Jun 30, 2021

$ 328.63M

Maximum

Jun 30, 2022

$ 98.72M

Average

$ 47.66M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M